Galychpharm PJSC (UKEX:GFARM) Current Ratio: 0.00 (As of . 20)


UKEX:GFARM Galychpharm PJSC UKEX:GFARM
14 GF Score
Price ₴100.00
! 1 Warning Sign
View Full Analysis

What is Galychpharm PJSC Current Ratio?

Galychpharm PJSC UKEX:GFARM 14 Current Ratio is 0.00 as of . 20. GuruFocus rates UKEX:GFARM with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Galychpharm PJSC's current ratio for the quarter that ended in . 20 was 0.00.

Galychpharm PJSC has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Galychpharm PJSC has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Galychpharm PJSC's Current Ratio or its related term are showing as below:

UKEX:GFARM's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2
* Ranked among companies with meaningful Current Ratio only.

Galychpharm PJSC  (UKEX:GFARM) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Galychpharm PJSC Current Ratio Related Terms


Galychpharm PJSC Current Ratio Historical Data

* Premium members only.

The historical data trend for Galychpharm PJSC's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galychpharm PJSC Current Ratio Chart

Galychpharm PJSC Annual Data
Trend
Current Ratio

Galychpharm PJSC Semi-Annual Data
Current Ratio

UKEX:GFARM vs HSTC, STLT, NTRR: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Galychpharm PJSC's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galychpharm PJSC Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galychpharm PJSC's Current Ratio distribution charts can be found below:

* The bar in red indicates where Galychpharm PJSC's Current Ratio falls into.


UKEX:GFARM
14GF Score
Galychpharm PJSC UKEX:GFARM
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galychpharm PJSC Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Galychpharm PJSC's Current Ratio for the fiscal year that ended in . 20 is calculated as

Current Ratio (A: . 20 )=Total Current Assets (A: . 20 )/Total Current Liabilities (A: . 20 )
=/
=

Galychpharm PJSC's Current Ratio for the quarter that ended in . 20 is calculated as

Current Ratio (Q: . 20 )=Total Current Assets (Q: . 20 )/Total Current Liabilities (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.00 mean?
Galychpharm PJSC (UKEX:GFARM) has a Current Ratio of 0.00 as of . 20.
Is Galychpharm PJSC's Current Ratio too high?
Galychpharm PJSC's current Current Ratio is 0.00. Overall, Galychpharm PJSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Galychpharm PJSC's Current Ratio compare to HSTC and STLT?
Galychpharm PJSC's Current Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Current Ratio is 2.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galychpharm PJSC's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galychpharm PJSC stock overvalued right now?
Galychpharm PJSC (UKEX:GFARM) has a current Current Ratio of 0.00. The current Current Ratio is 0.00. Galychpharm PJSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Galychpharm PJSC (UKEX:GFARM), the current Current Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galychpharm PJSC Business Description

Address 6/8 Opryshkivska Street, Lviv, UKR, 79024
Galychpharm PJSC is engaged in the production and sale of drugs and other medicines. It offers phytochemical substances, crude drugs, injection ampoules, tablets, solutions, extracts, and syrups.
14GF Score

Get the complete analysis for UKEX:GFARM

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴100.00
Price